TY - JOUR
AU - 
AB - Immunophenotyping of leukemias and other hematological neoplasms has become one of the most relevant clinical applications of flow cytometry which remains an indispensable tool for the diagnosis, classification, staging as well as hematologic malignancies monitoring. It can provide quantitative data on a number of cell parameters for a large number of cells in the region of cells thousands per second which making it a powerful diagnostic tool. If immunophenotyping is more sensitive significantly, specific and objective than morphological studying, the latter remains the gold standard criterion for creating and establishing the blast percentage in presentation and post treatment together. Moreover, it is important that interpreters of flow cytometric data have the phenotypes exact knowledge of diverse normal cell populations, which can be one of the best tool in recognize deviations from normal as well as are able to discuss the potential clinical significance and knowing look of the flow cytometric findings. Keywords: immunophenotyping; hematopoietic stem cell; progenitor cell; leukemia keep the potential for multi-lineage differentiation MPP can change to Introduction common myeloid progenitors (CMPs) and immature lymphoid progenitors population. On the other hand, the leukemic blasts clones of The multi-lineage process of hematopoiesis resulting in the peripheral different origin 
TI - Immunophenotyping Investigation in Acute and Chronic Leukemias as a Gold Standard Test
JO - Cancer Research and Cellular Therapeutics
DO - 10.31579/2640-1053/106
DA - 2022-01-10
UR - https://www.deepdyve.com/lp/unpaywall/immunophenotyping-investigation-in-acute-and-chronic-leukemias-as-a-zzGRUn4cdM
DP - DeepDyve
ER -